Gilead life sciences- An American Biopharmaceutical company has announced results of phase 3 trial of an antiviral drug called Remdesivir.. the results found effective...
Earlier USFDA had given an interim Approval based on phase 1/ 2 trial...
It appears until a vaccination is developed, Remdesivir can serve as an interim solution.
gilead.com/news-and-press/p...
WE wait for a vaccine that has had proper trials not one in a hurry.
Dear Sandy
Good morning !🙏
We are talking about two different things here!
(1) One is vaccine as you said everybody anxiously waiting for a preventive and proactive measure!
Hopefully, the vaccine would be successful at one shot..... and approx 8 billion doses would be required to cover the entire world .....
(2) Second is a treatment plan for the ones who are currently sufferring from Covid19 infections...and as of today there is no standard treatment plan... Nations are just having their own trial and error / Hit & miss methods of drug administration ......some country is using HCQS, and some are using a HIV drug/existing anti-viral drug, some one is using Remdesivir and some one is trying with Blood plasma from Antibodies from Covid19 cured person....
So there is a need for a standard treatment plan ... and USFDA seem to have given an interim solution fir Remdesivir based upon human trials by Gilead.
Stay Safe, Stay Healthy !
